FUCA Antibodies

Santa Cruz Biotechnology delivers a wide array of FUCA monoclonal antibodies for investigating fucosidase function and roles. FUCA monoclonal antibodies are compatible with multiple research applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Fucosidases play a critical role in fucose metabolism, a sugar essential for various biological processes, including cell signaling, immune response, and disease development. Research has shown that alterations in fucose metabolism can significantly impact tumor progression and immune evasion, making FUCA research particularly relevant in cancer and glycosylation studies. FUCA monoclonal antibodies enable researchers to examine enzyme activity, expression patterns, and cellular distribution in various experimental models. Understanding FUCA's role in normal physiology and disease states can lead to new therapeutic strategies and treatment approaches. Investigating FUCA's involvement in cellular processes provides valuable insights into potential drug targets and biomarker development. FUCA monoclonal antibodies from Santa Cruz Biotechnology support cutting-edge research that advances our understanding of fundamental biological processes and disease mechanisms.